ETF profile for State Street SPDR S&P Pharmaceuticals ETF (XPH) from the issuer: top holdings, net assets, expense ratio and shares outstanding.
XPH ETF Profile
| Family: |
State Street (SPDR) |
| Name: |
State Street SPDR S&P Pharmaceuticals ETF |
|
|
| Inception Date: |
19-Jun-2006 |
| Termination Date: |
|
| Investment Objective: |
State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "Index"), the Fund employs a sampling strategy, which means that the Fund is not required to purchase all of the securities represented in the Index. The Index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The S&P TMI is designed to track the broad U.S. equity market. The pharmaceuticals segment of the S&P TMI comprises the Pharmaceuticals sub-industry. The Index is one of twenty-one (21) of the S&P Select Industry Indices (the "Select Industry Indices"), each designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification Standard ("GICS"). |
|
|
| Prospectus |
|
|
|
| Top 10 Holdings |
|
|
| XERIS BIOPHARMA HOLDINGS INC |
XERS |
2.8292% |
| VERADERMICS INC |
MANE |
2.7734% |
| PACIRA BIOSCIENCES INC |
PCRX |
2.5610% |
| MAZE THERAPEUTICS INC |
MAZE |
2.3853% |
| AMNEAL PHARMACEUTICALS INC |
AMRX |
2.3685% |
| ELI LILLY + CO |
LLY |
2.2832% |
| VIATRIS INC |
VTRS |
2.2616% |
| PERRIGO CO PLC |
PRGO |
2.2440% |
| LIGAND PHARMACEUTICALS |
LGND |
2.2096% |
| ZOETIS INC |
ZTS |
2.1965% |
|
Top 10 Holdings Weight: |
24.1% |
| Number of Holdings: |
64 |
| Shares Outstanding: |
7,000,270 |
| Total Net Assets: |
449,977,344 |
| NAV: |
64.34 |
| Net Expense Ratio: |
0.35% |
|
|
| Asset Class: |
Equities (Stocks) |
| Developed or Emerging: |
Developed Market Funds |
| Country: |
US |
| Region: |
|
| Strategy: |
|
| Currency: |
|
| Commodity: |
|
| Sector: |
Healthcare |
| Industry: |
Pharmaceuticals |
| Dividend Type: |
|
| Tax Exempt State: |
|
| Maturity Duration: |
|
| Market Cap: |
Broad Market / Multi-Cap |
| Credit Quality: |
|
| Mortgage Bond Types: |
|
| Bond Type: |
|
| Gov't Bond Types: |
|
| Reit Type: |
|
| Leverage Direction/Factor: |
|
| Is Currency Hedged: |
No |
| US or Ex-US: |
Domestic |
